Phibro Animal Health (NASDAQ:PAHC) Posts Quarterly Earnings Results, Beats Estimates By $0.14 EPS

Phibro Animal Health (NASDAQ:PAHC) issued its quarterly earnings data on Wednesday. The company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14, Zacks reports. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. Phibro Animal Health updated its FY 2025 guidance to 1.870-2.010 EPS.

Phibro Animal Health Trading Up 1.6 %

Shares of NASDAQ PAHC traded up $0.35 during trading on Wednesday, hitting $22.37. 149,110 shares of the company traded hands, compared to its average volume of 141,187. The firm has a market capitalization of $905.99 million, a P/E ratio of 52.02, a P/E/G ratio of 0.56 and a beta of 0.52. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The company has a 50-day moving average price of $21.89 and a 200-day moving average price of $21.60. Phibro Animal Health has a 1 year low of $10.03 and a 1 year high of $25.98.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.15%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio is currently 111.63%.

Analyst Ratings Changes

PAHC has been the topic of several research reports. Morgan Stanley increased their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. StockNews.com raised Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a report on Wednesday, January 29th. Finally, Barclays lifted their price objective on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 12th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $20.50.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.